CRIS Current Research Information System

CAMPIERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.258
AS - Asia 8.207
EU - Europa 5.984
AF - Africa 536
SA - Sud America 491
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 24.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.103
VN - Vietnam 2.602
SG - Singapore 2.146
CN - Cina 1.759
GB - Regno Unito 1.339
IT - Italia 891
SE - Svezia 828
DE - Germania 758
HK - Hong Kong 591
FR - Francia 437
BR - Brasile 356
RU - Federazione Russa 349
IN - India 345
UA - Ucraina 302
IE - Irlanda 294
JP - Giappone 164
NL - Olanda 151
TG - Togo 139
FI - Finlandia 137
CI - Costa d'Avorio 129
ZA - Sudafrica 117
KR - Corea 110
BG - Bulgaria 100
CH - Svizzera 96
JO - Giordania 93
EE - Estonia 84
SC - Seychelles 83
CA - Canada 67
BE - Belgio 66
PH - Filippine 63
AR - Argentina 59
TH - Thailandia 40
BD - Bangladesh 37
IQ - Iraq 37
HN - Honduras 36
ID - Indonesia 33
PL - Polonia 32
TW - Taiwan 30
ES - Italia 26
NG - Nigeria 26
TR - Turchia 24
MX - Messico 22
GR - Grecia 21
IR - Iran 21
PK - Pakistan 20
UZ - Uzbekistan 20
AU - Australia 18
CL - Cile 18
EC - Ecuador 16
SA - Arabia Saudita 16
BZ - Belize 15
AT - Austria 12
CZ - Repubblica Ceca 12
CO - Colombia 11
MY - Malesia 11
PY - Paraguay 11
HR - Croazia 10
VE - Venezuela 10
RO - Romania 9
EG - Egitto 8
ET - Etiopia 8
LT - Lituania 7
PT - Portogallo 7
BH - Bahrain 6
IL - Israele 6
KE - Kenya 6
MA - Marocco 6
AZ - Azerbaigian 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
JM - Giamaica 4
KZ - Kazakistan 4
PE - Perù 4
CR - Costa Rica 3
DK - Danimarca 3
LB - Libano 3
MN - Mongolia 3
PS - Palestinian Territory 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
GE - Georgia 1
Totale 24.483
Salva come PNG Salva come JPEG
Città #
Singapore 1.468
Southend 1.110
Ashburn 1.030
Chandler 806
Fairfield 763
Hong Kong 551
Ho Chi Minh City 549
Santa Clara 476
Hanoi 434
Dong Ket 421
Woodbridge 411
San Jose 401
Houston 352
Princeton 348
Seattle 333
Wilmington 329
Dublin 293
Ann Arbor 291
Beijing 277
Cambridge 273
Boardman 186
Hefei 177
Lauterbourg 169
Jacksonville 166
Bologna 157
Lomé 139
Los Angeles 131
Abidjan 129
Tokyo 128
Berlin 127
Helsinki 126
Nanjing 124
Westminster 114
New York 108
Padova 104
Sofia 96
Milan 94
Amman 93
Da Nang 80
Bern 79
Buffalo 77
Frankfurt am Main 77
San Diego 75
Seoul 75
Haiphong 72
Shenyang 64
Turin 53
Dallas 52
Saint Petersburg 52
Phoenix 51
Guangzhou 50
Changsha 47
Redondo Beach 45
Hebei 43
Jinan 43
Brussels 42
Nanchang 42
Mülheim 38
Yubileyny 36
Bremen 34
Henderson 34
Medford 34
Redwood City 34
Council Bluffs 33
Shanghai 33
London 32
Munich 32
Rome 31
Washington 31
Falkenstein 29
Tianjin 29
Chicago 28
São Paulo 28
Centro 26
Saint Louis 26
Atlanta 25
Hải Dương 25
Orem 25
Bengaluru 24
Montreal 24
Dearborn 23
Olalla 23
Quận Bình Thạnh 23
Redmond 23
Jiaxing 22
Brierley Hill 21
Haikou 21
Toronto 20
Zhengzhou 20
Can Tho 19
Mahé 19
Nuremberg 19
Taizhou 19
Thái Nguyên 19
Warsaw 19
Mumbai 18
Ninh Bình 18
Abeokuta 17
Boston 17
Norwalk 17
Totale 15.491
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 656
Ulcerative Colitis 356
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 317
Essential oils as intestinal microbiota regulators in models of mice induced colitis. 314
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 290
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 266
Adult attachment and early parental experiences in patients with Crohn’s Disease 250
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 240
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 239
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 238
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 238
Antioxidant, anti-inflammatory, and microbial-modulating activities of essential oils: Implications in colonic pathophysiology 235
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 234
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 229
Attachment and perceived stress in patients with ulcerative colitis, a case–control study 228
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study 227
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 226
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 221
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 221
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 220
Medical treatment and management of severe ulcerative colitis 215
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 215
Infliximab in the treatment of Crohn's disease 212
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 212
Attachment and quality of life in patients with inflammatory bowel disease 210
High-dose probiotics for the treatment of active pouchitis 204
Attachment and mentalizing abilities in patients with inflammatory bowel disease 203
Influence of steroid treatment's duration in patients with active Crohn's disease 203
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 202
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 197
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 197
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 196
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 196
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 195
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 194
Clinical course of microscopic colitis in a single-center cohort study 192
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 191
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 190
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 187
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 187
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 186
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 186
Antibiotics and probiotics in treatment of inflammatory bowel disease 186
Management and treatment of distal ulcerative colitis 185
Alessitimia e stress percepito in 323 pazienti affetti da IBD 180
Oral budesonide in the treatment of chronic refractory pouchitis. 180
Role of conventional therapies in the era of biological treatment in Crohn's disease. 179
Review article: aminosalicylates for distal colitis 177
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 177
Parental Bonding and Inflammatory Bowel Disease 177
Management of inflammatory bowel disease: does rifaximin offer any promises 176
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 175
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 174
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 171
The role of Budesonide-MMX in active ulcerative colitis. 170
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 170
Antimicrobials in the management of inflammatory bowel disease 168
MANAGEMENT OF POUCHITIS 168
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 167
Which therapies are advisable in pouchitis? 165
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 165
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 164
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 163
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 163
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 161
Problematic proctitis and distal colitis 161
Sympathetic hyperactivity in patients with ulcerative colitis. 160
Randomized controlled trials in pouchitis 160
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 160
Oral beclomethasone dipropionate in chronic refractory pouchitis 159
null 159
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 156
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 156
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 155
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 155
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx 154
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 153
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 151
Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations 150
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 149
The role of antibiotics and probiotics in pouchitis 146
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 146
Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice 145
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. 144
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 141
Probiotic therapy to prevent pouchitis onset 141
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 140
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin 140
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. 138
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 137
The effects of probiotic bacteria on spontaneous contraction of isolated guinea-pig intestine 136
M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis 136
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients 135
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 134
TREATMENT OF PERIANAL CROHN'S DISEASE WITH COMBINED SURGICAL AND BIOLOGICAL THERAPY 134
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials 133
ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS 127
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 124
Totale 18.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021981 0 0 0 0 0 0 0 0 0 192 81 708
2021/20222.895 307 68 172 138 213 106 65 124 262 228 806 406
2022/20233.471 379 509 198 413 198 294 82 199 666 81 229 223
2023/2024989 69 147 92 77 98 272 46 51 21 61 27 28
2024/20253.291 176 490 291 218 649 158 207 111 41 219 95 636
2025/20267.561 913 626 666 532 903 524 777 249 1.833 538 0 0
Totale 25.068